全文获取类型
收费全文 | 7473篇 |
免费 | 328篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 186篇 |
妇产科学 | 29篇 |
基础医学 | 1270篇 |
口腔科学 | 93篇 |
临床医学 | 515篇 |
内科学 | 1553篇 |
皮肤病学 | 395篇 |
神经病学 | 719篇 |
特种医学 | 353篇 |
外科学 | 1003篇 |
综合类 | 31篇 |
一般理论 | 4篇 |
预防医学 | 302篇 |
眼科学 | 146篇 |
药学 | 597篇 |
中国医学 | 33篇 |
肿瘤学 | 582篇 |
出版年
2022年 | 33篇 |
2021年 | 50篇 |
2020年 | 46篇 |
2019年 | 76篇 |
2018年 | 100篇 |
2017年 | 81篇 |
2016年 | 93篇 |
2015年 | 130篇 |
2014年 | 174篇 |
2013年 | 245篇 |
2012年 | 365篇 |
2011年 | 390篇 |
2010年 | 233篇 |
2009年 | 261篇 |
2008年 | 439篇 |
2007年 | 533篇 |
2006年 | 489篇 |
2005年 | 497篇 |
2004年 | 454篇 |
2003年 | 487篇 |
2002年 | 454篇 |
2001年 | 95篇 |
2000年 | 87篇 |
1999年 | 129篇 |
1998年 | 130篇 |
1997年 | 127篇 |
1996年 | 127篇 |
1995年 | 81篇 |
1994年 | 92篇 |
1993年 | 83篇 |
1992年 | 60篇 |
1991年 | 48篇 |
1990年 | 47篇 |
1989年 | 37篇 |
1988年 | 52篇 |
1987年 | 42篇 |
1986年 | 28篇 |
1985年 | 26篇 |
1984年 | 46篇 |
1983年 | 38篇 |
1982年 | 53篇 |
1981年 | 37篇 |
1980年 | 40篇 |
1979年 | 32篇 |
1978年 | 34篇 |
1977年 | 29篇 |
1976年 | 35篇 |
1974年 | 32篇 |
1973年 | 26篇 |
1954年 | 29篇 |
排序方式: 共有7853条查询结果,搜索用时 31 毫秒
171.
Niethard FU Gold MS Solomon GS Liu JM Unkauf M Albrecht HH Elkik F 《The Journal of rheumatology》2005,32(12):2384-2392
OBJECTIVE: To assess the efficacy and safety of topical diclofenac diethylamine gel, 1.16%, 4 g applied qid for 3 weeks to relieve the symptoms of osteoarthritis (OA) of the knee. METHODS: Patients with OA of the knee washed out their OA medications for at least 5 drug half-lives. Patients with adequately high baseline pain scores were randomized to apply either double-blind active or placebo gel for 3 weeks. Acetaminophen (up to 2 g/day) was supplied as rescue medication. In a diary, patients recorded compliance to dosing and use of rescue medication and assessed daily pain on movement, spontaneous pain, and pain relief. At weekly site visits, patients completed the Western Ontario and McMaster (WOMAC) Osteoarthritis Index Questionnaire, which includes assessment of pain, stiffness, and physical function, and assessed pain intensity "right now." At the final visit, a global assessment of treatment efficacy was completed. RESULTS: Of 238 randomized patients, 237 were included in the intent to treat efficacy analysis. Treatments differed significantly for daily pain on movement at Day 5, and continued on most days through end of study. Peak differences were achieved in the second week. On the primary outcome, average pain on movement over Days 1-14, diclofenac gel was significantly superior to placebo gel. Scores for all 3 WOMAC indices for diclofenac gel treatment were significantly superior to placebo at Weeks 2 and 3. A significant difference was achieved on pain intensity "right now" at all 3 weeks. At the end of the study, patients rated diclofenac gel as significantly more effective in treating the pain of OA of the knee (p = 0.03) compared to placebo. There were no safety issues concerning adverse events or laboratory values. CONCLUSION: Diclofenac gel was effective and safe for relief of symptoms of OA of the knee over 3 weeks of dosing. 相似文献
172.
Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis 总被引:15,自引:0,他引:15
Tse HF Reek S Timmermans C Lee KL Geller JC Rodriguez LM Ghaye B Ayers GM Crijns HJ Klein HU Lau CP 《Journal of the American College of Cardiology》2003,42(4):752-758
OBJECTIVES: We sought to evaluate the efficacy and safety of pulmonary vein (PV) isolation using transvenous cryoablation for the treatment of atrial fibrillation (AF). BACKGROUND: Although electrical isolation of PVs with radiofrequency energy for the treatment of AF is feasible, it is associated with a significant risk of PV stenosis. Cryoablation is a new alternative therapy allowing ablation of tissue while preserving its underlying architecture. METHODS: In 52 patients with paroxysmal (n = 45) or persistent (n = 7) AF, PV isolation using the CryoCor cryoablation system (CyroCor Inc., San Diego, California) with a 10F deflectable transvenous catheter was performed as guided by ostial PV potentials. Cryoablation was applied twice at each targeted site (2.5 to 5 min/application). Computed tomography (CT) of the thorax was performed at baseline and at 3 and 12 months to evaluate for PV stenosis. RESULTS: All targeted PVs were completely isolated in 49 (94%) of 52 of patients. Of 152 PVs targeted, 147 (97%) were successfully isolated (mean 3.0 PVs isolated per patient). After a mean period of 12.4 +/- 5.5 months of follow-up, 37 (71%) of 52 patients had no recurrence of AF or were clinically improved, including 29 patients (56%) who had no recurrence of AF with (n = 11) or without the use of anti-arrhythmic drugs. At 3 and 12 months, the CT scan showed no evidence of PV stenosis associated with cryoablation in any patients. CONCLUSIONS: Transvenous catheter cryoablation is an effective method to create PV electrical isolation for the treatment of AF. A clinically satisfactory result can be achieved in 71% of patients with AF, without the risk of PV stenosis. 相似文献
173.
Chlormethiazole treatment prevents reduced hepatic vitamin A levels in ethanol-fed rats 总被引:3,自引:0,他引:3
Liu C Chung J Seitz HK Russell RM Wang XD 《Alcoholism, clinical and experimental research》2002,26(11):1703-1709
174.
Walter F. Haupt Felix Rosenow Christian van der Ven Helmut Borberg Gunter Pawlik 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》1997,1(1):55-57
Abstract: Plasma exchange and administration of intravenous immunoglobulin (IgG) are established treatments for Guillain-Barré syndrome (GBS). Elimination of postulated pathogenetic factors by plasma exchange or selective adsorption treatment using affinity-type adsorption columns and subsequent immunomodulation by intravenous IgG may provide a more effective treatment. Forty-five patients with acute GBS were prospectively examined using a clinical score. We treated 11 patients by plasma exchange, 13 patients by selective adsorption using a tryptophan-linked polyvinyl alcohol gel adsorbent, and 21 patients by selective adsorption followed by intravenous IgG. The patients treated sequentially by selective adsorption and intravenous IgG improved significantly better than the patients who received plasma treatment only. The results suggest that sequential treatment of GBS may be superior to plasma treatment alone. The higher cost of combined treatment may be offset by lower overall expenditure. 相似文献
175.
176.
Arthur J. Moss Mary W. Brown David S. Cannom James P. Daubert Mark Estes Elyse Foster Henry M. Greenberg W. Jackson Hall Steven L. Higgins Helmut Klein Mark Pfeffer David Wilber Wojciech Zareba 《Annals of noninvasive electrocardiology》2005,10(Z4):34-43
The planned MADIT‐CRT trial is designed to determine if CRT‐D will reduce the risk of mortality and HF events by approximately 25% in subjects with ischemic (NYHA class I‐II) and non‐ischemic (NYHA class II) cardiomyopathy, left ventricular dysfunction (EF ≤ 0.30), and prolonged intraventricular conduction (QRS duration ≥ 130 ms). 相似文献
177.
Kröger N Einsele H Wolff D Casper J Freund M Derigs G Wandt H Schäfer-Eckart K Wittkowsky G Schmitz N Krüger W Zabelina T Renges H Ayuk F Krüll A Zander A;German Study-group Multiple Myeloma 《Bone marrow transplantation》2003,31(11):973-979
We investigated toxicity and efficacy of in vivo T-cell depletion with anti-thymocyte globulin (ATG) as part of an intensified myeloablative conditioning regimen followed by allogeneic stem cell transplantation in patients with advanced multiple myeloma. The conditioning regimen consisted of modified total body irradiation, busulfan and cyclophosphamide (n=15) or in the case of prior dose-limiting radiotherapy of busulfan and cyclophosphamide (n=3). The median age was 44 years (range, 29-53) and the median time from diagnosis to transplant was 12 months (range, 6-144). Grade II-IV acute graft-versus-host disease (GvHD) occurred in six patients (35%). Severe grade III/IV GvHD developed in one patient (6%). Three patients died of therapy-related causes (17%). A complete remission (CR) with negative immunofixation after allogeneic transplantation was seen in eight of the evaluable patients (53%). After a median follow-up of 41 months (range, 8-84), the estimated overall survival at 6 years for all patients is 77% (CI 95%: 58-96%). The estimated progression-free survival at 6 years for all patients is 31% (CI 95%: 2-59%) and 46% (CI 95%: 9-83%) for patients with CR. In vivo T-cell depletion with ATG resulted in a low rate of severe GvHD with low treatment-related mortality, and a substantial number of long-term survivors. 相似文献
178.
Harald Kritz Peter Schmid Georgios Karanikas Christian Pirich Yannis Stamatopoulos Bernhard A. Peskar Prof. Helmut Sinzinger M.D. 《The International journal of angiology》1996,5(3):134-139
Although active smoking is known to enhance platelet thromboxane production, no data on passive smoking are available yet. In an 18 m3 room, the influence of single and repeated exposure to passive smoke for 60 minutes was assessed in nonsmokers and smokers. Smokers and nonsmokers were matched for sex and age. All the evaluated parameters (plasma TXB2, serum TXB2, malondialdehyde, 11-dehydro-TXB2, conversion of exogenous arachidonic acid to hydroxy-5,8,10-heptadecatrienoic acid, and TXB2) were higher in smokers than nonsmokers at baseline conditions, immediately and 6 hours after passive exposure to cigarette smoke. Repeated exposure of nonsmokers rendered their platelets more activated, so they became closer to the behavior of smokers. Contributing to the development of hemostatic imbalance, these results indicate that passive smoking may enhance thromboxane A2 release from the platelets.Presented at the 36th Annual World Congress, International College of Angiology, New York, New York, July 1994 相似文献
179.
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial 总被引:8,自引:3,他引:8
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kern W Haferlach T Schoch C Loffler H Gassmann W Heinecke A Sauerland MC Berdel W Buchner T Hiddemann W 《Blood》2003,101(1):64-70
Risk assessment in acute myeloid leukemia (AML) using pretreatment characteristics may be improved by incorporating parameters of early response to therapy. In the 1992 trial of the German AML Cooperative Group (AMLCG), the amount of residual leukemic blasts in bone marrow was assessed one week after the first induction course (day 16 blasts). A total of 449 patients 16 to 76 years of age (median, 53 years) with de novo AML entered the trial and were evaluable. Treatment included TAD/HAM (thioguanine, cytosine arabinoside, and daunorubicin/high-dose cytosine arabinoside and mitoxantrone) double induction, TAD consolidation, and randomly either maintenance therapy or S-HAM consolidation. Cytogenetics were favorable, intermediate, unfavorable and not available in 10.0%, 48.3%, 13.1%, and 28.5%, respectively. Day 16 blasts ranged from 0% to 100% (median, 5%, mean +/- SD, 18.6 +/- 28.5%). Complete remission (CR) rate was 72.6%, 17.6% had persistent leukemia (PL), and 9.8% succumbed to hypoplastic death. Median overall survival (OS), event-free survival (EFS), and relapse-free survival (RFS) were 18, 9, and 15 months with 28.4%, 21.6%, and 30.1% at 5 years, respectively. As a continuous variable, day 16 blasts were related to CR rate (P < 0.0001), PL rate (P < 0.0001), OS (P < 0.0001), EFS (P < 0.0001), and RFS (P = 0.0049). Multivariate analyses identified the following parameters to be associated with the respective end points. CR rate: day 16 blasts (P <.0001), age (P =.0036), and LDH (P =.0072); OS: unfavorable cytogenetics (P <.0001), day 16 blasts (P <.0001), age (P <.0001), and LDH (P =.0040); EFS: unfavorable cytogenetics (P <.0001), LDH (P <.0001), day 16 blasts (P <.0001), and age (P =.0061); RFS: unfavorable cytogenetics (P <.0001), LDH (P <.0001), and day 16 blasts (P =.0359). The prognostic significance of day 16 blasts is independent of pretherapeutic parameters and predicts outcome even in patients achieving a CR. 相似文献
180.